Design of new captopril mimics as promising ACE inhibitors: ADME, pharmacophore, molecular docking and dynamics simulation with MM-PBSA and PCA calculations

References

• Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788.
   PubMed Web of Science ®Google Scholar
• Townsend N, Kazakiewicz D, Lucy Wright F, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19:133–143.
   PubMed Web of Science ®Google Scholar
• Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101–106.
   PubMed Web of Science ®Google Scholar
• Valenzuela PL, Carrera-Bastos P, Gálvez BG, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18:251–275.
   PubMed Web of Science ®Google Scholar
• Sibai B. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–192.
   PubMed Web of Science ®Google Scholar
• Chiong JR, Aronow WS, Khan IA, et al. Secondary hypertension: current diagnosis and treatment. Int J Cardiol. 2008;124:6–21.
   PubMed Web of Science ®Google Scholar
• Brouwers S, Sudano I, Kokubo Y, et al. Arterial hypertension. Lancet. 2021;398:249–261.
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–1481.
   PubMed Web of Science ®Google Scholar
• Koch-Weser J, Vidt DG, Bravo EL, et al. Captopril. N Engl J Med. 1982;306:214–219.
   PubMed Web of Science ®Google Scholar
• Atkinson A, Robertson JI. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979;314:836–839.
   Google Scholar
• Unger T, Kaufmann-Bühler I, Schölkens B, et al. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1981;70:467–478.
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Langer A, Fu X, et al. ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer’s disease. Int J Mol Sci. 2013;14:16917–16942.
   PubMed Web of Science ®Google Scholar
• O’Caoimh R, Healy L, Gao Y, et al. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer’s disease. J Alzheimer’s Dis. 2014;40:595–603.
   PubMed Web of Science ®Google Scholar
• Alsharif NZ. Medicinal chemistry and therapeutic relevance of angiotensin-converting enzyme inhibitors. Am J Pharm Educ. 2007;71:123.
   PubMed Web of Science ®Google Scholar
• Martin MFR, Mckenna F, Bird HA, et al. Captopril: a new treatment for rheumatoid arthritis? Lancet. 1984;323:1325–1328.
   Google Scholar
• Waeber B, Gavras I, Brunner HR, et al. Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update. J Clin Pharmacol. 1981;21:508–516.
   PubMed Web of Science ®Google Scholar
• Natesh R, Schwager SLU, Evans HR, et al. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. 2004;43:8718–8724.
   PubMed Web of Science ®Google Scholar
• Schrödinger LLC. Schrödinger Release 2021-3: Maestro. Schrödinger LLC; 2021.
   Google Scholar
• Ntie-Kang F. An in silico evaluation of the ADMET profile of the StreptomeDB database. Springerplus. 2013;2:353.
   PubMedGoogle Scholar
• Sun X, Belal A, Elanany MA, et al. Identification of some promising heterocycles useful in treatment of allergic rhinitis: virtual screening, pharmacophore mapping, molecular docking, and molecular dynamics. Russ J Bioorganic Chem. 2022;48:438–456.
   PubMed Web of Science ®Google Scholar
• Kamel MS, Belal A, Aboelez MO, et al. Microwave-assisted synthesis, biological activity evaluation, molecular docking, and ADMET studies of some novel pyrrolo [2,3-b] pyrrole derivatives. Molecules. 2022;27:2061.
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Aboelez MO, Elsadek BEM, et al. Tolmetin sodium fast dissolving tablets for rheumatoid arthritis treatment: preparation and optimization using box-behnken design and response surface methodology. Pharmaceutics. 2022;14:880.
   PubMed Web of Science ®Google Scholar
• Natesh R, Schwager SLU, Sturrock ED, et al. Crystal structure of the human angiotensin-converting enzyme–lisinopril complex. Nature. 2003;421:551–554.
   PubMed Web of Science ®Google Scholar
• ULC, C.C.G. Molecular Operating Environment (MOE), 2019.01; 2020.
   Google Scholar
• Bhimaneni S, Kumar A. Abscisic acid and aloe-emodin against NS2B-NS3A protease of Japanese encephalitis virus. Environ Sci Pollut Res. 2022;29:8759–8766.
   PubMed Web of Science ®Google Scholar
• Belal A, Elkady H, Al-Karmalawy AA, et al. Discovery of some heterocyclic molecules as bone morphogenetic protein 2 (BMP-2)-inducible kinase inhibitors: virtual screening, ADME properties, and molecular docking simulations. Molecules. 2022;27:5571.
   PubMed Web of Science ®Google Scholar
• Elanany MA, Osman EEA, Gedawy EM, et al. Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis. Sci Rep. 2023;13:4144.
   PubMed Web of Science ®Google Scholar
• Belal A, Elanany MA, Santali EY, et al. Screening a panel of topical ophthalmic medications against MMP-2 and MMP-9 to investigate their potential in keratoconus management. Molecules. 2022;27:3584.
   PubMed Web of Science ®Google Scholar
• Belal A, Elanany MA, Raafat M, et al. Calendula officinalis phytochemicals for the treatment of wounds through matrix metalloproteinases-8 and 9 (MMP-8 and MMP-9): in silico approach. Nat Prod Commun. 2022;17:1934578X2210988.
   Web of Science ®Google Scholar
• Bauer P, Hess B, Lindahl E. GROMACS 2022.4 Source code; 2022.
   Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701–1718.
   PubMed Web of Science ®Google Scholar
• Maier JA, Martinez C, Kasavajhala K, et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696–3713.
   PubMed Web of Science ®Google Scholar
• Sousa da Silva AW, Vranken WF. ACPYPE - AnteChamber PYthon Parser interfacE. BMC Res Notes. 2012;5:367.
   PubMedGoogle Scholar
• Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A. 2001;105:9954–9960.
   Web of Science ®Google Scholar
• Belal A, Elsayed A, Gharib AF, et al. Toward the discovery of SARS-CoV-2 main protease inhibitors: exploring therapeutic potentials of evodiamine and its derivatives, virtual screening, molecular docking, and molecular dynamic studies. Nat Prod Commun. 2022;17:1934578X-2211430.
   Web of Science ®Google Scholar
• Nada H, Elkamhawy A, Lee K. Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations. PeerJ. 2022;10:e14120.
   PubMed Web of Science ®Google Scholar
• Miller BR, McGee TD, Swails JM, et al. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8:3314–3321.
   PubMed Web of Science ®Google Scholar
• Wang J, Cai Q, Xiang Y, et al. Reducing grid dependence in finite-difference Poisson–Boltzmann calculations. J Chem Theory Comput. 2012;8:2741–2751.
   PubMed Web of Science ®Google Scholar
• Valdés-Tresanco MS, Valdés-Tresanco ME, Valiente PA, et al. Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17:6281–6291.
   PubMed Web of Science ®Google Scholar
• Legler CR, Brown NR, Dunbar RA, et al. Scaled Quantum Mechanical scale factors for vibrational calculations using alternate polarized and augmented basis sets with the B3LYP density functional calculation model. Spectrochim Acta Part A Mol Biomol Spectrosc. 2015;145:15–24.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997). Adv Drug Deliv Rev. 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Vandenberg JI, Perry MD, Perrin MJ, et al. hERG K + channels: structure, function, and clinical significance. Physiol Rev. 2012;92:1393–1478.
   PubMed Web of Science ®Google Scholar
• Caballero J. Considerations for docking of selective angiotensin-converting enzyme inhibitors. Molecules. 2020;25:295.
   PubMed Web of Science ®Google Scholar
• Ke Z, Su Z, Zhang X, et al. Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening. Bioorg Med Chem Lett. 2017;27:3688–3692.
   PubMed Web of Science ®Google Scholar
• Liu X, Shi D, Zhou S, et al. Molecular dynamics simulations and novel drug discovery. Expert Opin Drug Discov. 2018;13:23–37.
   PubMed Web of Science ®Google Scholar